Brief: Acucort Receives Marketing Authorization For The Drug Zeqmelit By The Danish Medicines Agency
16/08/2022 16:52
Aug 16 (Reuters) - AcuCort AB ACUC.TE :
* ACUCORT RECEIVES MARKETING AUTHORIZATION FOR THE DRUG
ZEQMELIT
BY THE DANISH MEDICINES AGENCY
* REGISTRATION PROCESS FOR NORDIC MARKET IS ONGOING AND DRUG
IS
NOW APPROVED IN DENMARK AND SWEDEN
Source text for Eikon: ID:nWkrc5JTnP
Further company coverage: ACUC.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AcuCort AB
See all newsBrief: Acucort Plans To Apply For U.S. Market Approval For Zeqmelit In 2026
Brief: AcuCort Signs Its First Commercial Agreement For Zeqmelit
Brief: Acucort AB Acucort Receives Marketing Authorization For Drug Zeqmelit By Norwegian Medicines Agency
Brief: Acucort Receives Marketing Authorization For The Drug Zeqmelit By The Danish Medicines Agency
Brief: AcuCort Is Granted Sme Status By The European Medicines Agency, EMA